BioScrip Inc  

(Public, NASDAQ:BIOS)   Watch this stock  
Find more results for BIOS
15.98
+0.19 (1.20%)
Jun 18 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 15.63 - 16.01
52 week 6.14 - 16.16
Open 15.84
Vol / Avg. 953,404.00/607,523.00
Mkt cap 1.08B
P/E     -
Div/yield     -
EPS -0.24
Shares 67.53M
Beta 1.75
Inst. own 79%
Aug 9, 2013
Q2 2013 BioScrip Earnings Release Add to calendar
Jun 3, 2013
BioScrip at Jefferies Global Healthcare Conference - Webcast
May 10, 2013
Q1 2013 BioScrip Earnings Release
May 9, 2013
Q1 2013 BioScrip Earnings Conference Call - Webcast
May 7, 2013
BioScrip Annual Shareholder Meeting
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin -3.75% -1.26%
Operating margin -0.47% 2.01%
EBITD margin - 5.27%
Return on average assets -4.58% -1.26%
Return on average equity -10.32% -3.28%
Employees 2,112 -
Carbon Disclosure Rating - -

Address

100 Clearbrook Road
ELMSFORD, NY 10523
United States - Map
+1-914-4601600 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

BioScrip, Inc. (BioScrip) is a provider of pharmacy and home health services, which partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and the delivery of prescription medications and home health services. Its platform provides service capabilities and the ability to deliver clinical management services, which offers patients a community-based and home-based care environment. Its core services are provided in coordination with, and under the direction of the patient�s physician. Its home health professionals, including pharmacists, nurses, respiratory therapists and physical therapists, work with the physician to develop a plan of care suited to its patients� specific needs. In May 2012, Walgreen Co acquired certain assets of the Company's community specialty pharmacies and centralized specialty and mail service pharmacy businesses. On Febraury 1, 2013, it acquired HomeChoice Partners Inc.

Officers and directors

Myron Z. Holubiak Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Richard M. Smith President, Chief Executive Officer, Chief Operating Officer, Director
Age: 53
Bio & Compensation  - Reuters
Hai V. Tran Chief Financial Officer, Treasurer
Age: 43
Bio & Compensation  - Reuters
Brian Stiver Senior Vice President - National Infusion Sales
Age: 50
Bio & Compensation  - Reuters
Vito Ponzio Jr. Senior Vice President - Human Resources
Age: 58
Bio & Compensation  - Reuters
David Evans Senior Vice President - Strategic Operations
Age: 48
Bio & Compensation  - Reuters
Barbara Cormier Chief Compliance Officer and Privacy Officer
Age: 69
Bio & Compensation  - Reuters
Patricia Bogusz Vice President - Finance, Principal Accounting Officer
Age: 53
Bio & Compensation  - Reuters
Daniel Colucci Vice President - PBM Services
Age: 47
Bio & Compensation  - Reuters
Charlotte W. Collins Esq. Independent Director
Age: 60
Bio & Compensation  - Reuters